World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
123
Citations
62350
World Ranking
305
National Ranking
192

Medicine

D-Index
123
Citations
62350
World Ranking
3317
National Ranking
1826

Dan H. Barouch publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Dan H. Barouch sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 471 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Dan H. Barouch D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Dan H. Barouch sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 123 D-Index — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2020 - Member of the National Academy of Medicine (NAM)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Dan H. Barouch is affiliated with Harvard Medical School in the United States. Their research primarily focuses on medicine and immunology and microbiology, with substantial contributions in subfields such as infectious diseases, immunology, virology, molecular biology, and epidemiology.

The main topics of Barouch's work include:

  • SARS-CoV-2 and COVID-19 research
  • COVID-19 clinical research studies
  • HIV research and treatment
  • Animal virus infections studies
  • HIV/AIDS drug development and treatment
  • SARS-CoV-2 detection and testing
  • Immunotherapy and immune responses

Barouch has published extensively, with 545 publications in medicine and 156 in immunology and microbiology. The most frequent venues for publishing include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • UNC Libraries
  • Journal of Virology
  • npj Vaccines
  • Science Translational Medicine

Among the recent papers authored or co-authored by Barouch are:

  • Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19, 2021, New England Journal of Medicine
  • Correlates of protection against SARS-CoV-2 in rhesus macaques, 2020, Nature
  • Potently neutralizing and protective human antibodies against SARS-CoV-2, 2020, Nature
  • Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine, 2021, New England Journal of Medicine
  • DNA vaccine protection against SARS-CoV-2 in rhesus macaques, 2020, Science

Frequent co-authors collaborating with Barouch include Jingyou Yu, Katherine McMahan, Abishek Chandrashekar, Jinyan Liu, and Catherine Jacob-Dolan.

Barouch has been recognized with memberships in professional organizations such as the National Academy of Medicine (NAM) since 2020 and the Association of American Physicians.

Best Publications

  • Phenotypic Analysis of Antigen-Specific T Lymphocytes

    John D. Altman;Paul A. H. Moss;Philip J. R. Goulder;Dan H. Barouch

  • An immunogenic personal neoantigen vaccine for patients with melanoma

    Patrick A. Ott;Zhuting Hu;Derin B. Keskin;Derin B. Keskin;Sachet A. Shukla;Sachet A. Shukla

  • Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.

    Jerald Sadoff;Glenda Gray;An Vandebosch;Vicky Cárdenas

  • Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine.

    Jerald Sadoff;Mathieu Le Gars;Georgi Shukarev;Dirk Heerwegh

  • Potently neutralizing and protective human antibodies against SARS-CoV-2.

    Seth J. Zost;Pavlo Gilchuk;James Brett Case;Elad Binshtein

  • Correlates of protection against SARS-CoV-2 in rhesus macaques.

    Katherine McMahan;Jingyou Yu;Noe B. Mercado;Carolin Loos;Carolin Loos

  • Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA Vaccination

    Dan H. Barouch;Sampa Santra;Jörn E. Schmitz;Marcelo J. Kuroda

  • DNA vaccine protection against SARS-CoV-2 in rhesus macaques.

    Jingyou Yu;Lisa H. Tostanoski;Lauren Peter;Noe B. Mercado

  • SARS-CoV-2 infection protects against rechallenge in rhesus macaques.

    Abishek Chandrashekar;Jinyan Liu;Amanda J. Martinot;Amanda J. Martinot;Katherine McMahan

  • Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

    Dan H. Barouch;Jennifer Kunstman;Marcelo J. Kuroda;Jörn E. Schmitz

  • Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.

    Noe B. Mercado;Roland Zahn;Frank Wegmann;Carolin Loos;Carolin Loos

  • Animal models for COVID-19.

    César Muñoz-Fontela;William E. Dowling;Simon G.P. Funnell;Pierre S. Gsell

  • Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys

    Dan H. Barouch;James B. Whitney;Brian Moldt;Florian Klein

  • Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys

    James B. Whitney;Alison L. Hill;Srisowmya Sanisetty;Pablo Penaloza-MacMaster

  • Adenovirus serotype 5 hexon mediates liver gene transfer

    Simon N. Waddington;John H. McVey;David Bhella;Alan L. Parker

  • Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients.

    Anita S. Iyer;Forrest K. Jones;Ariana Nodoushani;Meagan Kelly

  • Challenges in the development of an HIV-1 vaccine.

    Dan H. Barouch

  • Comparative Seroprevalence and Immunogenicity of Six Rare Serotype Recombinant Adenovirus Vaccine Vectors from Subgroups B and D

    Peter Abbink;Angelique A. C. Lemckert;Bonnie A. Ewald;Diana M. Lynch

  • Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity

    Diane M. Roberts;Anjali Nanda;Menzo J. E. Havenga;Peter Abbink

  • Vaccine protection against Zika virus from Brazil

    Rafael A. Larocca;Peter Abbink;Jean Pierre S. Peron;Paolo M. de A. Zanotto

Frequent Co-Authors

Peter Abbink
Peter Abbink Harvard Medical School
Michael S. Seaman
Michael S. Seaman Beth Israel Deaconess Medical Center
Norman L. Letvin
Norman L. Letvin Beth Israel Deaconess Medical Center
Lindsey R. Baden
Lindsey R. Baden Brigham and Women's Hospital
Nelson L. Michael
Nelson L. Michael Walter Reed Army Institute of Research
Jaap Goudsmit
Jaap Goudsmit Harvard University
Michelle A. Lifton
Michelle A. Lifton Beth Israel Deaconess Medical Center
Mark G. Lewis
Mark G. Lewis Walter Reed Army Institute of Research
Bette T. Korber
Bette T. Korber Los Alamos National Laboratory

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related nursing degrees can open diverse career pathways. Many professionals start with foundational nursing roles before specializing through programs like cheapest online pmhnp certificate programs. These affordable options offer flexibility and quality education suited for working adults.

Earning a Doctor of Nursing Practice (DNP) degree enhances clinical expertise and leadership skills. Understanding how much does a dnp make helps gauge the financial benefits of this advanced degree in different states, allowing candidates to make informed decisions about investment and career growth.

Nurse Practitioners (NPs) can expand their scope by obtaining specialty certifications. For instance, transitioning from a Family Nurse Practitioner (FNP) to more specialized roles is supported by pathways like acute care certification for fnp, which prepares nurses to handle critical and complex patient care scenarios.

Accelerated learning options also exist for those with prior healthcare experience or degrees. Exploring accelerated np programs can fast-track entry into advanced nursing roles, making specialized immunology-related careers more accessible.

Best Scientists Citing Dan H. Barouch

Trending Scientists

Recently Published Articles